Pyruvate-enriched cardioplegia suppresses cardiopulmonary bypass-induced myocardial inflammation

Annals of Thoracic Surgery

Volumn 90, Issue 5, 2010, Pages 1529-1535

  Ryou, Myoung Gwi ^a,c   Flaherty, Devin C ^a,b,c   Hoxha, Besim ^b,c   Gurji, Hunaid ^a,b,c   Sun, Jie ^a   Hodge, Lisa M ^a   Olivencia Yurvati, Albert H ^a,b,c   Mallet, Robert T ^a,b,c  

^a University of North   (United States)

^b University of North Texas Health Science Center   (United States)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GELATINASE A; GELATINASE B; GLUCOSE; GLUTATHIONE; GLUTATHIONE DISULFIDE; MYELOPEROXIDASE; PYRUVIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE 2; ANTIOXIDANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY SINUS BLOOD FLOW; CRYSTALLOID; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HEART; HEART PROTECTION; HISTOLOGY; MALE; MYOCARDITIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; REPERFUSION; SWINE; WEANING; ANIMAL; BLOOD; HEART ARREST; HEART MUSCLE; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; C-REACTIVE PROTEIN; CARDIOPULMONARY BYPASS; FEMALE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HEART ARREST, INDUCED; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MYOCARDITIS; MYOCARDIUM; NEUTROPHIL INFILTRATION; PYRUVIC ACID; SWINE; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 78049233321     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2010.06.010     Document Type: Article

References (32)

1. L.H. Edmunds Inflammatory response to cardiopulmonary bypass Ann Thorac Surg 66 Suppl 1998 12 16
2. J.H. Levy, and K.A. Tanaka Inflammatory response to cardiopulmonary bypass Ann Thorac Surg 75 Suppl 2003 715 720
3. Y. Hayashi, Y. Sawa, S. Ohtake, N. Fukuyama, H. Nakazawa, and H. Matsuda Peroxynitrite formation from human myocardium after ischemia-reperfusion during open heart operation Ann Thorac Surg 72 2001 571 576
4. A. Anselmi, A. Abbate, and F. Girola Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence Eur J Cardiothorac Surg 25 2004 304 311
5. M.A. Moro, V. Darley-Usmar, and D.A. Goodwin Paradoxical fate and biological action of peroxynitrite on human platelets Proc Natl Acad Sci USA 91 1994 6702 6706
6. T. Okamoto, T. Akuta, F. Tamura, A. van der Vleit, and T. Akaike Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation Biol Chem 385 2004 997 1006
7. Z. Gu, M. Kaul, and B. Yan S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death Science 297 2002 1186 1190
8. R.T. Mallet, J. Sun, E.M. Knott, A.B. Sharma, and A.H. Olivencia-Yurvati Metabolic cardioprotection by pyruvate: recent progress Exp Biol Med 230 2005 435 443
9. P.D. Mongan, J. Capacchione, and S. West Pyruvate improves redox status and decreases indicators of hepatic apoptosis during hemorrhagic shock in swine Am J Physiol Heart Circ Physiol 283 2002 H16344
10. P.N. Slovin, C.-J. Huang, and J.R. Cade Sodium pyruvate is better than sodium chloride as a resuscitation solution in a rodent model of profound hemorrhagic shock Resuscitation 50 2001 109 115
11. R. Yang, D.J. Gallo, and J.J. Baust Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock Am J Physiol Gastrointest Liver Physiol 283 2002 G212 G221
12. T. Uchiyama, R.L. Delude, and M.P. Fink Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion Intensive Care Med 29 2003 2050 2058
13. E.M. Knott, M.-G. Ryou, and J. Sun Pyruvate-fortified cardioplegia suppresses oxidative stress and enhances phosphorylation potential of arrested myocardium Am J Physiol Heart Circ Physiol 289 2005 H1123 H1130
14. E.M. Knott, J. Sun, Y. Lei, M.-G. Ryou, A.H. Olivencia-Yurvati, and R.T. Mallet Pyruvate mitigates oxidative stress during reperfusion of cardioplegia-arrested myocardium Ann Thorac Surg 81 2006 928 934
15. M.G. Ryou, D.C. Flaherty, and B. Hoxha Pyruvate-fortified cardioplegia evokes myocardial erythropoietin signaling in swine undergoing cardiopulmonary bypass Am J Physiol Heart Circ Physiol 297 2009 H1914 H1922
16. D.P. Jones Extracellular redox state: refining the definition of oxidative stress in aging Rejuv Res 9 2006 169 181
17. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
18. S.-H. Koh, D.-I. Chang, and H.-T. Kim Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model Toxicology 214 2005 131 139
19. P.P. Bradley, D.A. Priebat, R.D. Christensen, and G. Rothstein Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker J Invest Dermatol 78 1982 206 209
20. S. Christen, B. Finckh, and J. Lykkesfeldt Oxidative stress precedes peak systemic inflammatory response in pediatric patients undergoing cardiopulmonary bypass operation Free Radic Biol Med 38 2005 1323 1332
21. I. Mayers, T. Hurst, and L. Puttagunta Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts J Thorac Cardiovasc Surg 122 2001 746 752
22. M.M. Lalu, E. Pasini, and C.J. Schulze Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart Eur Heart J 26 2005 27 35
23. C.-Y. Chan, Y.-S. Chen, and H.-H. Lee Erythropoietin protects post-ischemic hearts by preventing extracellular matrix degradation: role of Jak2-ERK pathway Life Sci 81 2007 717 723
24. W. Briest, L. Homagk, and H.A. Baba Cardiac remodeling in erythropoietin-transgenic mice Cell Physiol Biochem 14 2004 277 284
25. I. Jialal, S. Devaraj, and S.K. Venugopal C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 44 2004 6 11
26. S. Devaraj, M.R. Dasu, U. Singh, L.V.M. Rao, and I. Jialal C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo Atherosclerosis 203 2009 67 74
27. E.T.H. Yeh CRP as a mediator of disease Circulation 109 Suppl 2 2004 II11 II14
28. S. Verma, C.-H. Wang, and S.-H. Li A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis Circulation 106 2002 913 919
29. U. Singh, S. Devaraj, J. Vasquez-Vivar, and I. Jialal C-reactive protein decreases endothelial nitric oxide synthase through uncoupling J Mol Cell Cardiol 43 2007 780 791
30. C. Wanner, and T. Metzger C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients Nephrol Dial Transplant 17 Suppl 8 2002 29 32
31. M. Satoh, M. Nakamura, T. Akatsu, Y. Shimoda, I. Segawa, and K. Hiramori C-reactive protein co-expresses with tumor necrosis factor-α in the myocardium in human dilated cardiomyopathy Eur J Heart Fail 7 2005 748 754
32. R. Nijmeijer, W.K. Lagrand, and Y.T.P. Lubbers C-reactive protein activates complement in infarcted human myocardium Am J Pathol 163 2003 269 275